Did you know?

Institutional Ownership and Shareholders. Athersys Inc (US:ATHX) has 2 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 436 shares. Largest shareholders include Farther Finance Advisors, LLC, and AllSquare Wealth Management LLC .Athersys, Inc. (ATHX) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 0.1200 -0.1800 (-60.00%) At close: 04:00PM EDT 0.1395 +0.02 (+16.25%) Pre-Market: 09:11AM EDT Company...ATHX Athersys Inc 11,511 Watch Alerts $0.1395 $0.0195 (16.25%) Today About Feed News Sentiment Earnings Fundamentals There is no chart data available for this period 1d 1w 1m 3m 6m 1y All Sentiment Message Vol. Sentiment More 0 50 100 Fear Neutral Greed N/A Last score N/A 1 day ago Sign Up / Log In N/A Message Volume More ATHX Athersys Inc FDA Authorizes Initiation of a Phase 2 Trial Evaluating MultiStem® Cell Therapy in Trauma Patients Phase 2 study of cell therapy in trauma expands Company's clinical programs focused on critical care Athersys, Inc. (NASDAQ: ATHX) announced today that the U.S. Food and Drug Administration (FDA) ha...

ATHX Message Board The closing of the offering is expected to occur on or about August 21, 2023, subject to the satisfaction of customary closing conditions. The gross proceeds from the offering are expected to be approximately $3.5 million.Read Western Pennsylvania’s sports coverage on the latest news regarding the Pittsburgh Steelers, Pirates, Penguins, Pitt, Penn State, WPIAL high school sports.ATHX Athersys Inc Healios and Athersys Enter Into Regenerative Medicine Partnership for Treatment of Stroke Using MultiStem® Therapy CLEVELAND and TOKYO, Jan. 08, 2016 (GLOBE NEWSWIRE) -- Healios K.K. ('Healios') (Tokyo Stock Exchange: 4593) and Athersys, Inc. ('Athersys') (NASDAQ:ATHX) have announced a partnership …Track ProShares Trust - ProShares Ultra VIX Short-Term Futures ETF (UVXY) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the …$0.4418 $0.0042 (0.96%) Today $0.00 0.00 (0.00%) After Hours About Feed News Sentiment Earnings Fundamentals Disclaimer: This is informational only. Learn more Sentiment Indicates whether most users posting on a symbol's stream over the last 24 hours are fearful or greedy. 0 25 50 75 100 Extreme Fear Neutral Greed Extreme Fear Greed N/A

Addition deepens board expertise to prepare for future growth and potential commercialization of MultiStem® Athersys, Inc. (NASDAQ: ATHX), a clinical-stage regenerative medicine company, is pleased t...Athersys Inc (ATHX) Message Board - Company Name: Athersys Inc, Stock Symbol: ATHX, Industry: Biotechs - Total Posts: 3648 - Last Post: 08/23/2023 11:55:31 AM - company/specific stock board ….

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Athx message board. Possible cause: Not clear athx message board.

Athersys is a clinical-stage biotechnology company developing novel and proprietary best-in-class therapies designed to extend and enhance the quality of human life. Our focus is on the treatment of medical conditions where there is significant clinical need, and we are particularly focused on developing therapies in the regenerative medicine area.Athersys Inc. Athersys, Inc. (Nasdaq: ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announced today that it will be executing a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-25 after the close of trading on the Nasdaq Stock Market on Friday ...

ATHX Message Board CLEVELAND, Jan. 14, 2020 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX ) announced today the one-year follow-up summary results from its exploratory clinical study of the intravenous administration of MultiStem® cell therapy to treat patients who are suffering from acute respiratory distress syndrome …ATHX Athersys Inc Athersys Expands IP Protection with First New Patent for SIFU® Technology Novel Ultracold Storage System Ready for Commercial Licensing Athersys, Inc. (NASDAQ: ATHX), a cell therapy and regenerative medicine company developing MultiStem® (invimestrocel) for critical care i...Addition deepens board expertise to prepare for future growth and potential commercialization of MultiStem ® . Athersys, Inc. (NASDAQ: ATHX), a clinical-stage regenerative medicine company, is pleased to announce that it has appointed Ms. Katherine Kalin, Ms. Jane Wasman and Mr. Baiju R. Shah to its board of directors.Each of these …

david brown amarillo Discover historical prices for ATHX stock on Yahoo Finance. View daily, weekly or monthly format back to when Athersys, Inc. stock was issued. ATHX Athersys Inc Athersys Announces Fast Track Designation From FDA for MultiStem® Program for Acute Respiratory Distress Syndrome. CLEVELAND, May 14, 2019 (GLOBE NEWSWIRE) ... hibiclens bar soaphowl creator codes Apr 10, 2023 · Athersys, Inc. (NASDAQ: ATHX), a cell therapy and regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announced today it will host a business update conf... cs link provider login $0.4418 $0.0042 (0.96%) Today $0.00 0.00 (0.00%) After Hours About Feed News Sentiment Earnings Fundamentals Disclaimer: This is informational only. Learn more Sentiment Indicates whether most users posting on a symbol's stream over the last 24 hours are fearful or greedy. 0 25 50 75 100 Extreme Fear Neutral Greed Extreme Fear Greed N/A troy bilt starter solenoid7x10 rubbermaid shedhibbing obituary See More Posts on ATHX Message Board See More Message Board Posts. Historical ATHX Price Data. Period Open High Low VWAP Avg. Daily Vol Change % 1 Week: 0.32: 0.4501: 0.29: 0.3755239: 390,797: 0 ...$0.4418 $0.0042 (0.96%) Today $0.00 0.00 (0.00%) After Hours About Feed News Sentiment Earnings Fundamentals Disclaimer: This is informational only. Learn more Sentiment Indicates whether most users posting on a symbol's stream over the last 24 hours are fearful or greedy. 0 25 50 75 100 Extreme Fear Neutral Greed Extreme Fear Greed N/A cubic feet to pounds ATHX Athersys Inc Needham Thinks Athersys’ Stock is Going to Recover In a report issued on April 4, Gil Blum from Needham maintained a Buy rating on Athersys (ATHX – Research Report), with a price target of $5.00.1,888.70 +1.40(+0.07%) yearbook finderhome depot 11 percent rebate legitjosette pimenta only fans $0.4418 $0.0042 (0.96%) Today $0.00 0.00 (0.00%) After Hours About Feed News Sentiment Earnings Fundamentals Disclaimer: This is informational only. Learn more Sentiment Indicates whether most users posting on a symbol's stream over the last 24 hours are fearful or greedy. 0 25 50 75 100 Extreme Fear Neutral Greed Extreme Fear Greed N/A